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Abstract
We and others have recently shown that soyasaponins abundant in soybeans can decrease inflammation by suppressing
the nuclear factor kappa B (NF-kB)-mediated inflammation. However, the exact molecular mechanisms by which
soyasaponins inhibit the NF-kB pathway have not been established. In this study in macrophages, soyasaponins (A1, A2 and
I) inhibited the lipopolysaccharide (LPS)-induced release of inflammatory marker prostaglandin E2 (PGE2) to a similar extent
as the NF-kB inhibitor (BAY117082). Soyasaponins (A1, A2 and I) also suppressed the LPS-induced expression of
cyclooxygenase 2 (COX-2), another inflammatory marker, in a dose-dependent manner by inhibiting NF-kB activation. In
defining the associated mechanisms, we found that soyasaponins (A1, A2 and I) blunted the LPS-induced IKKa/b
phosphorylation, IkB phosphorylation and degradation, and NF-kB p65 phosphorylation and nuclear translocation. In
studying the upstream targets of soyasaponins on the NF-kB pathway, we found that soyasaponins (A1, A2 and I)
suppressed the LPS-induced activation of PI3K/Akt similarly as the PI3K inhibitor LY294002, which alone blocked the LPS-
induced activation of NF-kB. Additionally, soyasaponins (A1, A2 and I) reduced the LPS-induced production of reactive
oxygen species (ROS) to the same extent as the anti-oxidant N-acetyl-L-cysteine, which alone inhibited the LPS-induced
phosphorylation of Akt, IKKa/b, IkBa, and p65, transactivity of NF-kB, PGE2 production, and malondialdehyde production.
Finally, our results show that soyasaponins (A1, A2 and I) elevated SOD activity and the GSH/GSSG ratio. Together, these
results show that soyasaponins (A1, A2 and I) can blunt inflammation by inhibiting the ROS-mediated activation of the PI3K/
Akt/NF-kB pathway.
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Introduction
Excessive inflammation is associated with all sorts of chronic
diseases such as obesity, diabetes, cardiovascular disorders (CVD),
alcoholic and non-alcoholic fatty liver, Alzheimer’s disease, some
types of cancer, and accelerated aging, etc. [1–3]. Importantly,
reduction of inflammation by using various phytochemicals from
fruits, vegetables, whole grains and other plants may be used to
prevent all these chronic diseases [4–7]. One example of such
phytochemicals is components from soybeans [8,9].
Consumption of soybean and its products is strongly associated
with the reduced prevalence of diabetes, CVDs, Alzheimer’s
disease, and cancer and linked to longevity [10,11]. The associated
mechanisms have been under intense investigation but remain to
be defined. There is no doubt that phytochemicals from soy
products play an important role in all these benefits [12–14].
Soybean phytochemicals include isoflavones (0.1–0.3%), phytic
acids (1.0–2.2%), phytosterols (0.23–0.46%) and soyasaponins
(0.17–6.16%) [13]. Soyasaponins are abundant in soy products
and have been classified into 4 groups (A, B, E, and DDMP (2,3-
dihydro-2,5dihydroxy -6-methyl-4 H-pyran-4-one)) according to
their oleanane-type triterpenoid aglycone structure [15]. Groups A
and B are more abundant than the others [15]. Group A (A1, A2,
A3, A4, A5 and A6) has soyasapogenol A (SG-A) as its core
structural aglycone while group B (I, II, III, IV, and V) contains
soyasapogenol B (SG-B) [16]. Interestingly, soyasaponins have
been shown to be antimutagenic [17,18], anticarcinogenic [15,19],
anti-viral [20,21], hepatoprotective [22,23], and antioxidant [24],
and can reduce plasma level of cholesterol [25,26]. We have
recently shown that members from soyasaponins group A (A1 and
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A2) and B (I) can inhibit NO production in the LPS-stimulated
macrophages through inhibition of the nuclear factor kappa B
(NF-kB)-mediated iNOS expression [27]. Others have also shown
that soyasaponins can decrease inflammation by suppressing the
NF-kB-mediated transcription of inflammatory genes [28,29].
Nevertheless, the exact mechanisms by which soyasaponins
modulate NF-kB activation have not been defined. In this study,
we addressed this issue and found that soyasaponins modulates
NF-kB activation through the reactive oxygen species (ROS)-
mediated activation of PI3 K/Akt pathway in macrophages.
Experimental Procedures
Antibodies and reagents
Soyasaponins with different chemical structures (SS-A1, SS-A2
and SS-I) were prepared as previously described [27]. Polyclonal
antibodies against COX-2 (D5H5), phospho-NF-kB-p65 (Ser536),
NF-kB-p65, phospho-IkBa (Ser32), IkBa, phospho-IKKa/b
(Ser176/180), IKKb, phospho-PI3K-p85 (Tyr458) and PI3K-p85
were purchased from Cell Signaling Technology, Inc. (Danvers,
MA, USA). Antibodies to phospho-Akt (Ser473), Akt, lamin B1 and
b-actin, and lipopolysaccharides (LPS), N-acetyl-L-cysteine (NAC),
and 29, 79-dichlorofluorescein diacetate (DCF-DA) were from
Sigma (Saint Louis, MO, USA). All secondary antibodies used for
western blotting were from Rockland Immunochemical, Inc.
(Gilbertsville, PA, USA). The pharmaceutical inhibitor of NF-kB
(BAY117082) and PI3K (LY294002) were purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Cell culture
RAW264.7 murine macrophage cells from American Type
Culture Collection (ATCC) were cultured in Dulbecco’s Modified
Essential Medium (DMEM, Invitrogen) supplemented with 10%
(v/v) heat-inactivated fetal bovine serum (FBS, Gibco, Grand
Island, NY, USA), 2 mM L-glutamine, and penicillin (100 units/
mL)-streptomycin (100 mg/mL) at 37uC in an atmosphere of 5%
CO2.
PGE2 analysis
Cells were pretreated with SS (SS-A1, SS-A2 or SS-I) or
inhibitors and then stimulated by LPS for 16 h. Prostaglandin E2
(PGE2) in the culture media was quantified with an enzyme
immunoassay (EIA) kit (Cayman Chemical, Ann Arbor, MI, USA,
catalog no. 514010).
Immunoblotting blotting
Following the indicated treatment, cells were rinsed twice with
ice-cold PBS and then lysed with a lysis buffer (20 mM Tris-HCl,
pH 7.5, 137 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1%
Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM glycero-
phosphate, 1 mM Na3VO4, 2 mg/mL leupeptin, and 10 mg/mL
aprotinin) supplemented with 1 mM phenylmethylsulfonyl fluo-
ride before use. Lysates (30 mg/lane) were resolved in 4–12% Tris
glycine gels (Invitrogen) and transferred to nitrocellulose mem-
branes (Bio-Rad). The presence of proteins was detected by
immunoblotting with primary antibodies as indicated and alkaline
phosphatase- conjugated secondary antisera. Fluorescent bands
were visualized using the Odyssey infrared imaging system
(ODYSSEY Fc station, LI-COR).
Real-time fluorescent quantitative polymerase chain
reaction (PCR)
Following treatment, cells were harvested and total RNA was
isolated using TRIZOL reagent (Sigma) according to the
manufacturer’s protocol. First-strand cDNA was synthesized from
total RNA using the AMV reverse transcriptase (Promega,
Madison, WI, USA) with indicated primers (COX-2: sense 59-
TCTCCAACCTCTCCTACTAC-39, antisense 59-GCACG-
TAGTCTTC GATCACT-39; b-actin: sense 59-GATGGTGG-
GAATGGGTCA GA-39, antisense 59-TCCATGTCGTCC-
CAGTTGGT-39). PCR was performed in 20 ml volume of
mixtures containing 1 mg of cDNA template, 0.5 mM each of
the primers, and SYBR Green Real-time PCR Master Mix
(TOYOBO, Kita-ku, Osaka, Japan, code no. QPK-201 & 201 T)
by using a continuous fluorescence detector (ABI 7500, USA).
Samples were normalized by dividing the quantity of the COX-2
gene by the value of a house-keeping gene (b-actin) in the same
sample. Results were presented as COX-2 mRNA relative
expression (folds to the negative control which denoted as 1).
Preparation of cytoplasmic and nuclear extracts
Cells were washed with ice-cold PBS twice, scraped, collected
and transferred into clean centrifuge tubes. Cell pellets were
processed to separate the cytoplasmic and nuclear fractions using
the CHEMICON’s nuclear extraction kit (EMD Millipore
Corporation, Temecular, CA, USA, catalog no. 2900) according
to the manufacturer’s instructions. Protein concentration in the
supernatant was quantified by Pierce Bicinchoninic Acid (BCA)
protein assay kit (Thermo Scientific, Rockford, IL, USA, catalog
no. 23225 & 23227).
pNF-kB-Luc reporter gene assay
The commercially available plasmid pNF-kB-Luc (Stratagene,
Jalla, CA, USA) was used to assess the NF-kB activity. Briefly,
RAW264.7 cells were cultured in a 60-mm dish. After confluence,
cells were then transfected with the plasmid by using Lipofect-
AMINE reagent (Life Technologies, Inc. Grand Island, NY). After
24 h of incubation, cells were trypsinized and reseeded equally
into 6-well plates. After another 24 h, cells were treated as noted.
Cells were subsequently harvested and luciferase activities were
determined according to manufacturer’s instructions. Results were
described as relative luciferase activity (fold difference compared to
the negative control).
Detection of reactive oxygen species (ROS)
Fluorescent DCF-DA was used to detect intracellular ROS. The
nonfluorescent dye can freely permeate into cells, in which it is
deesterified to form the ionized free acid (dichlorofluorescein) and
reacts with ROS to form fluorescent 29, 79-dichlorofluorescein
(DCF). Following indicated treatment, cells were washed with PBS
three times and loaded with 20 mmol/L DCF-DA at 37uC for
30 min to allow complete deesterification of the dye. DCF
fluorescence was quantified by using a fluorescence plate reader
(Spectramax Gemini EM, Molecular Devices, Eugene, OR) at the
excitation and emission wavelengths of 490 nm and 530 nm,
respectively.
Determination of SOD activity, GSH/GSSG ratio and
malondialdehyde (MDA) levels
Commercial assay kits were correspondingly used for the
determination of superoxide dismutase (SOD determination kit,
Sigma-Aldrich, Saint Louis, MO, catalog no. 19160), reduced and
oxidized glutathione (BIOXYTECH GSH/GSSG-412, OxisRe-
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search, Manhattan Beach, CA, catalog no. 21040), and mal-
ondialdehyde (TBARS Assay kit, Cayman Chemical Company,
Ann Arbor, MI, catalog no. 10009055) according to the
recommended protocols.
Statistical analysis
Statistical analyses were performed using one way analysis of
variance (one-way ANOVA) and LSD multiple comparison tests
by SPSS 11.5 statistical software (SPSS Inc., Chicago, IL, USA).
Data are presented as means 6 SD of three independent
experiments. Significant values (P,0.05) were marked with an
asterisk (*) or an octothorpe (#).
Results
Soyasaponins blunt the LPS-induced release of
inflammatory marker PGE2 in macrophages
To determine the effect of soyasaponins on inflammation,
RAW264.7 macrophages were treated with LPS in the absence or
presence of an increasing amount of soyasaponins, followed by
measurements of inflammatory markers (PGE2 and COX-2). As
shown in Fig. 1A, the level of PGE2 in the control was very low,
and incubation with soyasaponins (A1, A2, or I) alone at 40 mM for
16 h did not alter the level of PGE2. PGE2 level was dramatically
increased by LPS, but the elevation was prevented by all
soyasaponins (A1, A2 and I) in a concentration-dependent manner.
Similarly, expression of the COX-2 gene (mRNA and protein) was
stimulated by LPS (Fig. 1B–C), and the stimulation was blunted
by all soyasaponins (A1, A2 and I) in a concentration-dependent
manner. Treatment of macrophages with soyasaponins at all these
concentrations did not cause detectable cytotoxicity (data not
shown). Together, these results show that soyasaponins can
prevent or reduce the level of inflammation.
Soyasaponins blunt the release of inflammatory marker
PGE2 in macrophages similarly as an inhibitor of NF-kB
The NF-kB-mediated signaling pathway is the primary player in
the LPS-induced inflammatory responses [30]. To determine the
mechanism by which soyasaponins blunt the LPS-stimulated
inflammation, macrophages were pretreated with soyasaponins
(A1, A2, or I) or the specific inhibitor of NF-kB, BAY117082, prior
to the LPS stimulation. The level of PGE2 in the media was
subsequently quantified. As shown in Fig. 2, soyasaponins (A1, A2
and I) blunted the LPS-induced release of PGE2 in the same way
as the NF-kB inhibitor BAY117082. These results imply that the
effect of soyasaponins on the LPS-stimulated PGE2 release is
associated with inhibition of the NF-kB signaling pathway.
Soyasaponins inhibit the LPS-induced activation of NF-kB
in macrophages
To define the involvement of the NF-kB pathway in the
soyasaponins-mediated suppression of the LPS-induced inflam-
mation, activity of the NF-kB signaling pathway was evaluated by
measuring the level of a luciferase-labeled NF-kB. As shown in
Fig. 3A, the LPS-induced activation of NF-kB was blunted by all
soyasaponins (A1, A2, and I). LPS stimulated NF-kB p65
phosphorylation and the stimulation was blunted by using
soyasaponins A1, A2, or I (Fig. 3B). Moreover, LPS enhanced
the nuclear translocation of the NF-kB p65 subunit, and the
enhancement was prevented largely by soyasaponins A1, A2, or I
(Fig. 3C). Together, these results demonstrate that soyasaponins
can effectively inhibit the whole pathway of the NF-kB signaling.
Figure 1. Soyasaponins blunt the LPS-induced release of inflammatory markers in macrophages. Cells were pre-treated with increasing
amount of soyasaponins (A1, A2 and I) for 30 min and then treated with LPS (1 mg/mL) for 16 h as noted. Some cells were treated with soyasaponins
alone for the same amount of time. PGE2 in the media was then quantified with enzyme immunoassays (A). Total RNA was isolated and COX-2 mRNA
level was determined by using real-time PCR (B). Protein level of the COX-2 gene was evaluated with immunoblotting (C). Results represent means6
SD of 3 independent experiments. *: P,0.05 vs. control. #: P,0.05 vs. LPS alone.
doi:10.1371/journal.pone.0107655.g001
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Soyasaponins influence NF-kB activation by modulating
phosphorylation and degradation of IkB
Since phosphorylation and degradation of IkB protein are
critical steps for activation of the NF-kB signaling pathway [31],
we measured the effect of soyasaponins on the LPS-initiated
phosphorylation and degradation of NF-kB. As shown in Fig. 4,
LPS stimulated the phosphorylation and degradation of IkB, and
the stimulation was prevented largely by all soyasaponins (A1, A2,
or I). These results support the notion that soyasaponins influence
NF-kB activation by modulating phosphorylation and degradation
of IkB.
Soyasaponins influence NF-kB activation through
modulation of IKKa/b phosphorylation
To further investigate the mechanism of soyasaponin suppres-
sion of NF-kB activation, we examined the effect of soyasaponins
(A1, A2 and I) on the LPS-stimulated phosphorylation of IKKa/b,
an upstream regulator of the phosphorylation and degradation of
IkB [32]. As shown in Fig. 5, LPS stimulated phosphorylation of
IKKa/b and the stimulation was blunted by soyasaponin A1, A2,
or I. These results further support the notion that soyasaponins
can inhibit activation of NF-kB pathway via the classical cascade
of the signaling pathway.
Figure 2. Soyasaponins blunt the release of inflammatory
marker PGE2 in macrophages similarly as an inhibitor of NF-kB.
Cells were pre-treated with the NF-kB inhibitor (BAY117082, 10 mmol/L)
or soyasaponins (A1, A2 and I, 40 mmol/L) for 30 min and then
stimulated with LPS (1 mg/mL) for 16 h as indicated. PGE2 in the media
was quantified with enzyme immunoassays. Results are presented as
means 6 SD of 3 independent experiments. *: P,0.05 vs. control. #:
P,0.05 vs. LPS alone.
doi:10.1371/journal.pone.0107655.g002
Figure 3. Soyasaponins inhibit the LPS-induced activation of NF-kB in macrophages. (A) The pNF-kB-Luc reporter plasmid was introduced
into macrophages via transient transfection and then stimulated for 16 h with 1 mg/mL LPS in the absence or presence of increased concentrations of
soyasaponins (10–40 mmol/L). The level of luciferase activity was quantified determined and presented as fold of the negative control, which was set
as 1. (B) Macrophages were pre-treated with 10, 20, or 40 mmol/L of soyasaponins (A1, A2 and I) for 2 h, and then stimulated with LPS (1 mg/mL) for
15 min as noted. Levels of targets proteins in the whole cell lysates were evaluated with immunoblotting. (C) Macrophages were pre-treated with 10,
20, or 40 mmol/L of soyasaponins (A1, A2 and I) for 2 h, and then stimulated with LPS (1 mg/mL) for 1 h as noted. The level of p65 in the nuclear and
cytosolic extracts was determined by using immunoblotting. Lamin B1 was used as the nuclear protein marker and b-actin as the cytosolic protein
marker. Results are presented as means 6 SD of 3 independent experiments. *: P,0.05 vs. control. #: P,0.5 vs. LPS alone.
doi:10.1371/journal.pone.0107655.g003
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Soyasaponins inhibit the LPS-induced PI3K/Akt activation
in macrophages
It has been shown that LPS can activate the PI3 K/Akt
pathway, which in turn has been shown to be able to activate the
NF-kB signaling pathway through IKKa/b in other cell types
[33,34]. To determine whether or not soyasaponins blunted the
LPS-induced activation of NF-kB via this pathway in macrophag-
es, we examined the effect of soyasaponins on the LPS-induced
phosphorylation of Akt and p85 (a regulatory subunit of PI3 K).
Indeed, LPS induced marked phosphorylation of both Akt and
p85 in macrophages (Fig. 6A–B), and the induction was blunted
by soyasaponin (A1, A2 and I) in a dose-dependent manner.
Interestingly, inhibition of PI3 K with LY294002 completely
abolished the LPS-induced activation of p85 and Akt (Fig. 6C)
and the whole cascade of the NF-kB signaling components
including phosphorylations of p85, Akt, IKKa/b, IkBa and p65,
and NF-kB activity (Fig. 6D). Besides, inhibition of PI3 K with
LY294002 markedly decreased the NF-kB-dependent luciferase
expression induced by LPS (Fig. 6E). It is noteworthy that the
PI3 K inhibitor LY294002 dramatically reduced the LPS-induced
release of PGE2 (Fig. 6F) similarly as soyasaponins (see Fig. 1).
Together, these results imply that the PI3 K/Akt pathway
mediates NF-kB activation and soyasaponins can blunt the NF-
kB-mediated inflammation probably by inhibiting the PI3 K/Akt
pathway in macrophages.
Soyasaponins blunts the LPS-induced ROS production in
macrophages
It has been shown that ROS can mediate the LPS-induced
inflammation through the Akt-mediated activation of NF-kB in
hepatocytes [35]. To determine whether this is also true in
macrophages and the targets of soyasaponins, we investigated the
potential role of ROS. As shown in Fig. 7A, treatment with LPS
elevated the intracellular level of ROS, but the elevation was
prevented by soyasaponin A1, A2 or I in a dose-dependent
manner. Treatment with soyasaponin (A1, A2 or I) alone did not
affect ROS production. When a well-established anti-oxidant,
NAC, was added, the LPS-induced ROS production was
completely blocked (Fig. 7A). The co-treatment with NAC and
soyasaponins (A1, A2 or I) did not further reduce ROS production,
Figure 4. Soyasaponins influence the LPS-stimulated activation
of NF-kB through modulating the degradation and phosphor-
ylation of IkBa in macrophages. Macrophages were pre-treated
with 10, 20, or 40 mmol/L of soyasaponins (A1, A2 and I) for 2 h, and
then stimulated with LPS (1 mg/mL) for 10 min or 30 min as indicated.
Phosphorylation and degradation of IkBa were detected by immuno-
blotting, and b-actin was used as a control. Results are presented as
means 6 SD of 3 independent experiments. *: P,0.05 vs. control. #:
P,0.05 vs. LPS alone.
doi:10.1371/journal.pone.0107655.g004
Figure 5. Soyasaponins influence the LPS-stimulated activation
of NF-kB through modulation of IKKa/b phosphorylation in
macrophages. Macrophages were pre-treated with 10, 20, or
40 mmol/L of soyasaponins (A1, A2 and I) for 2 h, and then stimulated
with LPS (1 mg/mL) for 15 min as indicated. Phospho-IKKa/b and total
IKKb were detected by immunoblotting and b-actin was used as a
control. Results are presented as means 6 SD of 3 independent
experiments. *: P,0.05 vs. control. #: P,0.05 vs. LPS alone.
doi:10.1371/journal.pone.0107655.g005
Soyasaponins Antagonize Inflammation through NF-kB
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e107655
indicating that soyasaponins suppressed ROS to the same extent
as NAC. Furthermore, treatment with NAC abolished the LPS-
induced production of PGE2 (Fig. 7B), NF-kB activation
(Fig. 7C), and phosphorylation of Akt, IkBa, IKKa/b and p65
(Fig. 7D). Co-treatment with NAC and soyasaponins did not
further augment the inhibitory ability of NAC (Fig. 7B–D).
Finally, the LPS-induced production of oxidized lipid malondial-
dehyde (MDA) was also prevented by NAC and soyasaponins to
the same extent (Fig. 7E). Taken together, these results suggest
that soyasaponins (A1, A2 or I) can blunt the LPS-induced
inflammation in macrophages by suppressing the ROS-mediated
PI3 K/Akt and NF-kB activation.
Soyasaponins increase SOD activity and GSH/GSSG ratio
It is known that the immune cells use ROS to support their
functions and on the other hand they also need adequate amounts
of antioxidation defense to avoid the adverse effect of excessive
ROS [36]. Therefore, we further investigated the effects of
soyasaponins (A1, A2 or I) on SOD activity and GSH/GSSG ratio
in the LPS-stimulated macrophages. As shown in Fig. 8, LPS
markedly reduced SOD activity and the GSH/GSSG ratio,
whereas treatment of NAC completely abolished this effect.
Similarly, soyasaponins (A1, A2 or I) reversed the suppressive effect
of LPS on SOD activity and GSH/GSSG ratio in a dose-
dependent manner. Together, these results show that soyasaponins
promote the anti-oxidation system.
Discussion
We and others have recently discovered that soyasaponins can
antagonize inflammation and inhibit the NF-kB signaling path-
way. Here we further defined the exact effect of soyasaponins on
each component of the NF-kB signaling cascade and made some
new observations, in particular, about the initial target of
soyasaponin modulation of the NF-kB signaling pathway.
First, soyasaponins modulates the NF-kB signaling likely by
inhibiting the PI3K/Akt-mediated signaling. It has previously
been shown that the PI3K/Akt signaling pathway can be an
upstream activator of the NF-kB signaling cascade [33,34]. In this
study, our results clearly show that soyasaponins can modulate
every step of the NF-kB signaling pathway similarly as the specific
inhibitor of NF-kB. In exploring how soyasaponins influence the
initiation steps of NF-kB pathway, we found that soyasaponins
could reduce the LPS-induced activations of both PI3K/Akt and
NF-kB signaling pathways to the same extent as either the PI3K or
NF-kB inhibitor. This implies that soyasaponins modulates the
NF-kB signaling through the PI3K/Akt signaling pathway. This
observation is important not only for understanding how
soyasaponins can modulate the NF-kB signaling and inflammation
directly, but also for fully understanding the comprehensive effects
of soyasaponins on metabolism because the PI3K/Akt-dependent
signaling is the central regulator of the insulin-mediated metab-
olism [37]. We have recently shown that the basal level of the
Figure 6. Soyasaponins prevent the LPS-induced PI3K/Akt activation in macrophages. Macrophages were pre-treated with 10, 20, or
40 mmol/L of soyasaponins (A1, A2 and I) for 2 h, and then stimulated with LPS (1 mg/mL) for 30 min as noted. Phospho- and total Akt and p85 were
detected by using immunoblotting (A–B). (C) Macrophages were pre-treated with 40 mmol/L of soyasaponins (A1, A2 or I) or 25 mmol/L of LY294002
(a PI3K inhibitor) for 2 h, and then stimulated with LPS (1 mg/mL) for 30 min as noted. Phospho- and total of Akt and p85 were subsequently
detected by using immunoblotting. (D) Macrophages were pre-treated with 25 mmol/L of LY294002 for 2 h and then stimulated with LPS (1 mg/mL)
for 30 min, 15 min or 10 min as indicated. Phosph- and/or total p85, Akt, IKKa/b, IkBa and p65 were detected by using immunoblotting. (E) The pNF-
kB-Luc plasmids were introduced into macrophages using transient transfection for overnight, and then stimulated with 1 mg/mL of LPS in the
absence or presence of LY294002 (25 mmol/L) for 16 h as noted. The level of luciferase activity was evaluated and presented as fold of the negative
control. (F) Macrophages were pre-treated with 25 mmol/L of LY294002 for 2 h, and then stimulated with 1 mg/mL of LPS for 16 h, followed by
measurement of PGE2 in the media with an enzyme immunoassay. Results are presented as means6 SD of 3 independent experiments. *: P,0.05 vs.
control. #: P,0.05 vs. LPS alone.
doi:10.1371/journal.pone.0107655.g006
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Figure 7. Soyasaponins blunt the LPS-induced ROS production in macrophages. Macrophages were pre-treated with NAC (15 mmol/L) or/
and soyasaponins (A1, A2 or I) for 30 min, and then stimulated with LPS (1 mg/mL) for 16 h as noted. Intracellular ROS level was subsequently
quantified by using fluorescent DCF-DA probe and quantified as described in Materials and Methods (A). The level of PGE2 in the media was
determined by using an enzyme immunoassay (B). (C) The pNF-kB-Luc reporter plasmid was introduced into macrophages via transient transfection
for overnight, and then stimulated for 16 h with 1 mg/mL LPS in the presence of NAC or NAC plus 40 mmol/L of SS (A1, A2 or I) as noted. The level of
luciferase activity was determined and presented as the fold of the negative control. (D) Macrophages were pre-treated with NAC alone or NAC plus
40 mmol/L of SS (A1, A2 or I) for 2 h, and then stimulated with LPS (1 mg/mL) for 10 min (for detection of p-IkBa and b-actin), 15 min (for detection of
p-IKKa/b, IKKb, p-p65 and p65) or 30 min (for detection of p-Akt and Akt) as noted. Protein levels were detected by using immunoblotting. b-actin
was used as a loading control. (E) Macrophages were pre-treated with NAC (15 mmol/L) or soyasaponin (A1, A2 or I) for 30 min, and then stimulated
with LPS (1 mg/mL) for 16 h as noted, followed by measurements of MDA in the whole cell lysates. Results are presented as means 6 SD of 3
independent experiments. *: P,0.05 vs control. #: P,0.05 vs LPS alone.
doi:10.1371/journal.pone.0107655.g007
Figure 8. Soyasaponins increase SOD activity and GSH/GSSG ratio in the LPS-stimulated macrophages. Macrophages were pre-treated
with NAC (15 mmol/L) or soyasaponin (A1, A2 or I) for 30 min, and then stimulated with LPS (1 mg/mL) for 16 h as noted, followed by measurements
of SOD activity (A) and GSH/GSSG ratio (B). Results are presented as means 6 SD of 3 independent experiments. *: P,0.05 vs. control. #: P,0.05 vs.
LPS alone.
doi:10.1371/journal.pone.0107655.g008
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PI3K/Akt-dependent signaling is increased in the diet-induced
insulin resistance and hyperinsulinemia [38]. Insulin resistance/
hyperinsulinemia is a precursor and key component of all sorts of
metabolic diseases such as metabolic syndrome, type 2 diabetes
mellitus, atherosclerotic heart and brain disorders, fatty liver,
Alzheimer’s disease, some types of cancer, and aging [39–47].
Therefore, soyasaponins can be potentially used to prevent and/or
reverse all these major health problems by neutralizing the
excessive basal activity of PI3K/Akt signaling. In support of this
notion, various reports have shown that consumption of soybeans
or their products is associated with a lower rate of cancer
[17,48,49]. The suppressive effect of soyasaponins on the PI3K/
Akt pathway discovered in this study might be an important
contributor to the reduced rate of cancer.
Another important finding from this study is that soyasaponins
can modulate the NF-kB signaling by scavenging ROS through
up-regulation of the most important anti-oxidation system SOD.
Specifically, treatment with soyasaponins decreased the LPS-
elevated levels of ROS and MDA while increasing the activity of
SOD. Typically, SOD activity is increased in the presence of the
elevated production of ROS as a defensive mechanism against
oxidative stress [50]. In this study, the presence of soyasaponins led
to decreased ROS level together with increased SOD activity.
That strongly indicates that soyasaponins can directly promote the
SOD-mediated anti-oxidation system. Previously, soyasaponins
have been shown to have antioxidant activities but the conclusion
is debatable. Specifically, Yoshiki and Okubo reported that 1 mg/
mL of DDMP soyasaponin (bg) scavenged superoxide at a degree
equivalent to 17.1 units of SOD/mL [51]. Another study showed
that soyasaponin I could scavenge DPPH radicals with a 50%
inhibitory concentration of 70.2 mM comparable to the DPPH
radical scavenging activity of a-tocopherol (IC50 = 52.1 mM) [29].
However, others have shown that soyasaponin I (bg) did not have
scavenging activity due to lack of DDMP moiety [51]. Here we
show that soyasaponins scavenge ROS by activating SOD
although the exact mechanism remains to be defined. It is well
known that ROS can activate all sorts of intracellular signaling
pathways such as MAPK (p38, JNK, and ERK1/2), PKCs, NF-
kB, and PI3K/Akt etc. [52]. Since soyasaponins can reduce ROS
production likely through promoting SOD activity, it is likely that
soyasaponins can also modulate these signaling pathways and then
influence many other aspects of cellular functions. Defining the
effects of soyasaponins in all these pathways and their impact on
various cellular functions and activities will definitely help explain
the wide spectrum of beneficial effects of soyasaponins on human
health.
In summary, results from this study show that soyasaponins can
affect activation of each step of the NF-kB signaling pathway. The
Figure 9. Schematic diagram of the targets of soyasaponins.
doi:10.1371/journal.pone.0107655.g009
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main and new discoveries of this study are the effect of
soyasaponins on the initiation steps of NF-kB signaling including
the involvement of PI3K/Akt and SOD activation (Fig. 9). These
results are important for explaining the multi-faucets beneficial
effects of soyasaponins in human health.
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